TrialInflammopharmacology2018

Targeting of circulating Th17 cells by β-D-mannuronic acid (M2000) as a novel medication in patients with rheumatoid arthritis.

Hossein Ahmadi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.